조직 및 계약 가격을 보려면 로그인를 클릭합니다.
크기 선택
보기 변경
제품정보 (DICE 배송 시 비용 별도)
NACRES:
NB.13
UNSPSC Code:
41122104
Binding type:
Tissue Culture (TC)-treated surface
Material:
U-bottom flask, canted neck neck, cap (Vented), polystyrene , vent cap
Sterility:
sterile
Packaging:
pkg of 100 ea
Feature:
cap, tissue culture treated
material
U-bottom flask, canted neck neck, cap (Vented), polystyrene , vent cap
sterility
sterile
feature
cap, tissue culture treated
packaging
pkg of 100 ea
manufacturer/tradename
Corning 430641U
capacity
45 mL
flask surface area
(75 cm2)
binding type
Tissue Culture (TC)-treated surface
General description
Corning′s enhanced T-75 Flask features a U-shaped design, which improves usability while maintaining the same environment for cell growth as previous designs.
Application
Corning® 75 cm² U-shape cell culture flask, a canted neck has been used in tissue culture experiments for routine passaging or further downstream assays, and cell culture and selection experiments.
Features and Benefits
- Surface treated for optimal cell attachment
- U-shaped flasks have fewer corners for easy cell scraping
- Rounded shoulders of the flasks improve grip and access when removing or tightening the cap
- cGMP manufacturing
- Optimized cell growth area
- Stable stacking design
- Large, clear viewing surface
- High standards of quality (100% leak tested)
- Nonpyrogenic (<0.1 EU/mL)
- BSE/TSE compliant
- Canted neck for easier pouring and large pipet access
Legal Information
Corning is a registered trademark of Corning, Inc.
Approaches for the sensitive detection of rare base and prime editing events
Tran MTN, et al.
Methods, 75-82 (2021)
VEGAS as a Platform for Facile Directed Evolution in Mammalian Cells
English JG, et al.
Cell Journal, 748-761 (2019)
Karina M Lugo-Cintrón et al.
EBioMedicine, 73, 103634-103634 (2021-10-22)
In head and neck cancer, intratumour lymphatic density and tumour lymphangiogenesis have been correlated with lymphatic metastasis, making lymphangiogenesis a promising therapeutic target. However, inter-patient tumour heterogeneity makes it challenging to predict tumour progression and lymph node metastasis. Understanding the